Cooper Companies (COO) Competitors

Cooper Companies logo
$71.02 +0.38 (+0.54%)
Closing price 06/26/2026 04:00 PM Eastern
Extended Trading
$71.94 +0.92 (+1.30%)
As of 06/26/2026 06:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

COO vs. ALC, WST, ALGN, MMSI, and ICUI

Should you buy Cooper Companies stock or one of its competitors? MarketBeat compares Cooper Companies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cooper Companies include Alcon (ALC), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), and ICU Medical (ICUI). These companies are all part of the "medical" sector.

How does Cooper Companies compare to Alcon?

Cooper Companies (NASDAQ:COO) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

Alcon has a net margin of 7.70% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.88% beat Alcon's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
Alcon 7.70%7.11%4.98%

Cooper Companies has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market. Comparatively, Alcon has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 53.9% of Alcon shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 1.5% of Alcon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Cooper Companies had 23 more articles in the media than Alcon. MarketBeat recorded 24 mentions for Cooper Companies and 1 mentions for Alcon. Alcon's average media sentiment score of 0.83 beat Cooper Companies' score of 0.61 indicating that Alcon is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Alcon
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies presently has a consensus price target of $81.31, indicating a potential upside of 14.49%. Alcon has a consensus price target of $85.12, indicating a potential upside of 25.60%. Given Alcon's stronger consensus rating and higher possible upside, analysts plainly believe Alcon is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38
Alcon
1 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.63

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.38$374.90M$1.1860.19
Alcon$10.40B3.22$980M$1.6640.83

Summary

Alcon beats Cooper Companies on 10 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to West Pharmaceutical Services?

Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.38$374.90M$1.1860.19
West Pharmaceutical Services$3.22B7.70$493.70M$7.4846.93

Cooper Companies has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market.

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cooper Companies presently has a consensus price target of $81.31, suggesting a potential upside of 14.49%. West Pharmaceutical Services has a consensus price target of $340.09, suggesting a potential downside of 3.13%. Given Cooper Companies' higher probable upside, research analysts plainly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38
West Pharmaceutical Services
0 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
3.00

In the previous week, Cooper Companies had 15 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 24 mentions for Cooper Companies and 9 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 0.94 beat Cooper Companies' score of 0.61 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
West Pharmaceutical Services
5 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has a net margin of 16.85% compared to Cooper Companies' net margin of 5.57%. West Pharmaceutical Services' return on equity of 19.03% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
West Pharmaceutical Services 16.85%19.03%14.06%

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Align Technology?

Cooper Companies (NASDAQ:COO) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Align Technology has higher revenue and earnings than Cooper Companies. Align Technology is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.38$374.90M$1.1860.19
Align Technology$4.10B3.12$410.35M$5.9629.94

Cooper Companies has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, indicating that its share price is 67% more volatile than the broader market.

Align Technology has a net margin of 10.50% compared to Cooper Companies' net margin of 5.57%. Align Technology's return on equity of 15.82% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
Align Technology 10.50%15.82%10.17%

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Cooper Companies had 19 more articles in the media than Align Technology. MarketBeat recorded 24 mentions for Cooper Companies and 5 mentions for Align Technology. Align Technology's average media sentiment score of 0.72 beat Cooper Companies' score of 0.61 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Align Technology
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies presently has a consensus target price of $81.31, suggesting a potential upside of 14.49%. Align Technology has a consensus target price of $205.85, suggesting a potential upside of 15.37%. Given Align Technology's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38
Align Technology
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.71

Summary

Align Technology beats Cooper Companies on 12 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Merit Medical Systems?

Cooper Companies (NASDAQ:COO) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Cooper Companies had 21 more articles in the media than Merit Medical Systems. MarketBeat recorded 24 mentions for Cooper Companies and 3 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.36 beat Cooper Companies' score of 0.61 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Merit Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies presently has a consensus price target of $81.31, indicating a potential upside of 14.49%. Merit Medical Systems has a consensus price target of $92.80, indicating a potential upside of 29.37%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

Cooper Companies has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.38$374.90M$1.1860.19
Merit Medical Systems$1.52B2.82$128.49M$2.3131.05

Merit Medical Systems has a net margin of 9.03% compared to Cooper Companies' net margin of 5.57%. Merit Medical Systems' return on equity of 13.54% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
Merit Medical Systems 9.03%13.54%7.94%

Cooper Companies has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market.

Summary

Merit Medical Systems beats Cooper Companies on 9 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to ICU Medical?

Cooper Companies (NASDAQ:COO) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

In the previous week, Cooper Companies had 19 more articles in the media than ICU Medical. MarketBeat recorded 24 mentions for Cooper Companies and 5 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.80 beat Cooper Companies' score of 0.61 indicating that ICU Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
ICU Medical
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market.

Cooper Companies presently has a consensus price target of $81.31, indicating a potential upside of 14.49%. ICU Medical has a consensus price target of $168.40, indicating a potential upside of 13.58%. Given Cooper Companies' higher probable upside, research analysts plainly believe Cooper Companies is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38
ICU Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.88

Cooper Companies has a net margin of 5.57% compared to ICU Medical's net margin of 2.15%. Cooper Companies' return on equity of 10.88% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
ICU Medical 2.15%7.50%3.91%

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 2.1% of ICU Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cooper Companies has higher revenue and earnings than ICU Medical. Cooper Companies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.38$374.90M$1.1860.19
ICU Medical$2.23B1.66$730K$1.8580.15

Summary

Cooper Companies beats ICU Medical on 10 of the 17 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesMED/DENTAL IndustryMedical SectorNASDAQ Exchange
Market Cap$13.78B$16.29B$6.70B$12.22B
Dividend YieldN/A1.30%2.67%6.12%
P/E Ratio60.1918.0625.7624.17
Price / Sales3.382.30556.3798.88
Price / Cash11.6614.1846.9954.37
Price / Book1.683.3610.776.35
Net Income$374.90M$534.24M$3.57B$337.63M
7 Day Performance7.75%3.64%2.15%0.06%
1 Month Performance16.81%5.40%1.06%-0.15%
1 Year Performance-0.17%2.54%34.16%27.55%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.1804 of 5 stars
$71.02
+0.5%
$81.31
+14.5%
+1.9%$13.78B$4.09B60.1915,000
ALC
Alcon
4.083 of 5 stars
$64.77
+0.1%
$85.12
+31.4%
-22.3%$32.04B$10.40B39.0225,942
WST
West Pharmaceutical Services
3.4491 of 5 stars
$328.48
+0.2%
$340.09
+3.5%
+59.9%$23.21B$3.07B43.9110,800
ALGN
Align Technology
2.6806 of 5 stars
$182.08
flat
$205.85
+13.1%
-5.0%$13.04B$4.03B30.5520,290
MMSI
Merit Medical Systems
4.344 of 5 stars
$67.22
flat
$92.80
+38.1%
-22.7%$4.01B$1.52B29.107,500

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 6/27/2026 by MarketBeat.com Staff.
From Our Partners